共 50 条
- [41] Effect of a high-protein diet with -cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trialTRIALS, 2018, 19Haidari, FatemehHojhabrimanesh, AbdollahHelli, BizhanSeyedian, Seyed SaeidAhmadi-Angali, Kambiz
- [42] Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trialTrials, 19Fatemeh HaidariAbdollah HojhabrimaneshBizhan HelliSeyed Saeid SeyedianKambiz Ahmadi-Angali
- [43] A NONINVASIVE DIAGNOSTIC MODEL FOR LIVER CIRRHOSIS IN PATIENTS WITH HBV INFECTION BASED ON CHI3L1 AND ROUTINE CLINICAL PARAMETERSHEPATOLOGY, 2023, 78 : S418 - S418Xie, ZhiweiLin, JinnianLi, ChujingWang, WenyuLiu, SonglianBai, HonglianLi, JianpingGuan, Yujuan
- [44] Efficacy of Atorvastatin Plus Aspirin in Comparison with Atorvastatin Alone on Liver Function and Degree of Fibrosis in Patients with Cryptogenic Cirrhosis: A Randomized Double-Blind Clinical TrialHEPATITIS MONTHLY, 2019, 19 (11)Ghadir, Mohammad RezaSarkeshikian, Seyed SaeedHormati, AhmadAlemi, FaezehAlavinejad, PezhmanJameshorani, MaryamMolaei, MansourehJahangiry, Mahdi
- [45] Reductions in liver stiffness by magnetic resonance elastography (MRE) predict fibrosis improvement in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)HEPATOLOGY, 2017, 66 : 1109A - 1110ALoomba, RohitLawitz, EricGhalib, ReemElkhashab, MagdyCaldwell, Stephen H.Abdelmalek, Manal F.Kowdley, Kris V.Xu, RenHan, LingLi, YaoDjedjos, Constantine S.Myers, Robert P.Subramanian, ManiGoodman, Zachary D.Charlton, MichaelSirlin, Claude B.Middleton, Michael S.
- [46] Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trialBMC Research Notes, 12Zahra DarabiMina DarandZahra YariMehdi HedayatiAmirhosein FaghihiShahram AgahAzita Hekmatdoost
- [47] Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trialBMC RESEARCH NOTES, 2019, 12 (1) : VDarabi, ZahraDarand, MinaYari, ZahraHedayati, MehdiFaghihi, AmirhoseinAgah, ShahramHekmatdoost, Azita
- [48] Letter to the editor about "the effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial"SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) : 222 - 222Soto-Mota, AdrianPerichart-Perera, Otilia
- [49] Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY, 2020, 73 : S508 - S508Alkhouri, NaimWong, Vincent Wai-SunJablkowski, Maciejde Guevara, Alma Laura LadronSheikh, MuhammadHodge, AlexElkhashab, MagdyStrasser, SimonePark, Grace S.Landgren, HenrikTan, BillMassetto, BenedettaPecoraro, Maria LuciaSeyedkazemi, StarMartins, Eduardo BrunoFischer, LaurentAbdelmalek, ManalTetri, BrentAnstee, Quentin
- [50] Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialDIABETES THERAPY, 2021, 12 (03) : 843 - 861Chehrehgosha, HalehSohrabi, Masoud RezaIsmail-Beigi, FaramarzMalek, MojtabaBabaei, Mohammad RezaZamani, FarhadAjdarkosh, HosseinKhoonsari, MahmoodFallah, Afshin EshghiKhamseh, Mohammad E.